Your browser doesn't support javascript.
loading
Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review.
Chang, Yaping; Guyatt, Gordon H; Teich, Trevor; Dawdy, Jamie L; Shahid, Shaneela; Altman, Jessica K; Stone, Richard M; Sekeres, Mikkael A; Mukherjee, Sudipto; LeBlanc, Thomas W; Abel, Gregory A; Hourigan, Christopher S; Litzow, Mark R; Michaelis, Laura C; Alibhai, Shabbir M H; Desai, Pinkal; Buckstein, Rena; MacEachern, Janet; Brignardello-Petersen, Romina.
Affiliation
  • Chang Y; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Guyatt GH; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Teich T; Drexel University College of Medicine, Philadelphia, Pennsylvania, United States of America.
  • Dawdy JL; School of Nursing, McMaster University, Hamilton, Ontario, Canada.
  • Shahid S; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
  • Altman JK; Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
  • Stone RM; Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.
  • Sekeres MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
  • Mukherjee S; Leukemia Program, Cleveland Clinic, Cleveland, Ohio, United States of America.
  • LeBlanc TW; Leukemia Program, Cleveland Clinic, Cleveland, Ohio, United States of America.
  • Abel GA; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States of America.
  • Hourigan CS; Division of Hematologic Malignances and Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
  • Litzow MR; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Michaelis LC; Division of Hematology, Mayo Clinic, Rochester, Minnesota, United States of America.
  • Alibhai SMH; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, United States of America.
  • Desai P; Department of Medicine, University Health Network & University of Toronto, Toronto, Ontario, Canada.
  • Buckstein R; Weill Cornell Medicine, New York City, New York, United States of America.
  • MacEachern J; Odette Cancer Centre, Division of Medical Oncology and Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Brignardello-Petersen R; Grand River Regional Cancer Centre, Kitchener, Ontario, Canada.
PLoS One ; 16(3): e0249087, 2021.
Article in En | MEDLINE | ID: mdl-33784346
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute Type of study: Clinical_trials / Observational_studies / Systematic_reviews Limits: Aged / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute Type of study: Clinical_trials / Observational_studies / Systematic_reviews Limits: Aged / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2021 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos